Nutritional support for migraine sufferers
NeuroFlavin™ features riboflavin and CoQ10, key compounds in the citric acid cycle and the respiratory chain, to help offset the reduced energy production that is sometimes associated with neurologic distress. NeuroFlavin™ also features patented, high-absorption dimagnesium malate to help insure adequate serotonin activity, to enhance the synthesis of prostaglandins and nitric oxide, and for other essential neurologic functions.
Several studies have found that riboflavin reduced the intensity and frequency of migraine headaches by at least 50 percent in close to 60 percent of patients beginning in the third month of therapy. In a 3-month, randomized trial, 55 patients with migraine were given either riboflavin or a placebo. Riboflavin was superior to placebo in reducing attack frequency and headache days. Only 15 percent of the subjects taking a placebo improved, but 59 percent of the riboflavin group experienced at least a 50 percent improvement. Because effect in these studies was not observed until the third month of treatment, compliance and persistence with treatment are necessary. However, many experts agree that lower doses of riboflavin may be just as helpful as the higher doses used in some of the earlier studies.
Similar to riboflavin, coenzyme Q10 improves mitochondrial energy metabolism and therefore also has produced good results in migraine sufferers. In a double-blind, randomized, placebo-controlled trial, researchers compared CoQ10 and placebo in 42 migraine patients. By the third month of supplementation, CoQ10 was superior to placebo in reducing attack frequency, the number of days subjects had headaches and days-with-nausea in the third treatment month. For migraine attack frequency, the number of subjects experiencing at least a 50 percent improvement was only 14.4 percent for the placebo group and 47.6 percent for the CoQ10 group.
Studies have indicated magnesium may be another natural substance useful for migraine prophylaxis. A double-blind, randomized, placebo-controlled study compared oral magnesium supplementation in 30 migraine patients without aura to 10 migraine patients taking a placebo. Migraine attack frequency and severity were found to be significantly lower in the magnesium group compared to those in the placebo group. In another randomized, double blind, placebo-controlled study of children with migraines, researchers found a statistically significant decrease over time in headache frequency in the group taking magnesium but not in the placebo group.
Dosage:
Take 2 capsules two times per day or as directed by your healthcare professional.
Caution:
If you are under a physician's care or taking medication, or if you are pregnant or nursing, consult your healthcare professional before using this product.
| Product Specifications: |
Serving Size: 2 Capsules
Servings Per Container: 60 |
| Amount Per Serving | % Daily Value |
| Vitamin B2 (riboflavin) | 50mg | 2,940% |
Magnesium
(from dimagnesium malate) | 150mg | 270% |
| CoQ10 | 100mg | * |
| *Daily Value not established |
Other Ingredients:
Hydroxypropylmethylcellulose (vegetarian capsule), magnesium stearate, microcrystalline cellulose and silicon dioxide.
Contains no added sugar, starch, salt, wheat, gluten, corn, coloring, dairy products, flavoring, or preservatives.
Keep container tightly closed in a cool, dry and dark place. Keep out of reach of children. |
